Photo from wikipedia
This study assessed the effects of semaglutide on body weight, cardiometabolic risk factors, and glycemic status in individuals categorized by baseline BMI with or without additional obesity‐related comorbidities, including prediabetes… Click to show full abstract
This study assessed the effects of semaglutide on body weight, cardiometabolic risk factors, and glycemic status in individuals categorized by baseline BMI with or without additional obesity‐related comorbidities, including prediabetes and high risk of cardiovascular disease (CVD).
Keywords:
weekly semaglutide;
comorbidities efficacy;
bmi comorbidities;
impact bmi;
efficacy weekly;
bmi
Journal Title: Obesity
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Obesity
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!